EPISPOT Detection of Circulating Prostate Cells Among Adenocarcinoma Patients

Centre Hospitalier Universitaire de Nīmes

Status: Unknown

Conditions: Adenocarcinoma of the Prostate

Treatments: Biological: CellSearch detection of the number of circulating, functional, prostate cells; Biological: EPISPOT detection of the number of circulating cells

Study type: Observational

Funder types: Other

Identifiers

NCT01402154

2011-A00328-33 (Other Identifier)

AOI/2010/SD-01

Details and patient eligibility

About

The primary objective of this study is to evaluate the predictive value (in terms of remission) of a new technique for detecting circulating, functional, prostate cells among patients with localized adenocarcinoma of the prostate, and prior to any treatment.

Enrollment: 361 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The patient must have given his/her informed and signed consent
• The patient must be insured or beneficiary of a health insurance plan
• Histologically proven presence of prostate adenocarcinoma
• Localized disease on digital rectal examination
• Cancer without extensions
• Acceptance of a curative treatment by the patient

Exclusion criteria

• The patient is participating in another study
• The patient is in an exclusion period determined by a previous study
• The patient is under judicial protection, under tutorship or curatorship
• The patient refuses to sign the consent
• It is impossible to correctly inform the patient
• The patient is taking a hormone-modifying treatment
• Patient taking adrogenic supplements

Trial design

361 participants in 1 patient group

All study patients

Description:

All patients included according to stated inclusion and exclusion criteria.

Treatment:

Biological: CellSearch detection of the number of circulating, functional, prostate cells

Biological: EPISPOT detection of the number of circulating cells